Based on studies, modifying the expression of genes that regulate UCP-2 expression and functions is a promising therapeutic approach for controlling insulin resistance, obesity, and body-weight gain or body mass index (BMI) [19]. The gene discussed is UCP2; the disease is obesity disorder.